Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer? Academic Article uri icon

Overview

publication date

  • April 1, 2006

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Breast Neoplasms
  • Receptor, ErbB-2

Identity

Scopus Document Identifier

  • 33645711515

Digital Object Identifier (DOI)

  • 10.1038/ncponc0460

PubMed ID

  • 16596138

Additional Document Info

volume

  • 3

issue

  • 4